Peyronie disease trials attribute penile curvature improvements to injection therapies, but do not account for the placebo response.
Clinically indistinguishable prognostic information seen for kidney and cardiovascular outcomes with UACR, UPCR.
The FDA has approved Gazyva (obinutuzumab) to reduce relapse risk in adult and pediatric patients aged 2 years and older with idiopathic nephrotic syndrome.
A 67-year-old male patient initially presented with a PSA of 12. He ultimately underwent a prostate needle biopsy, with 3/8 ...
A high genetic risk score was associated with an elevated risk for progression in patients with lower-risk cancers.
The Frame-to-Outcome (F2O) system analyzes surgical video to predict surgery patient recovery, another use case for AI in ...
Robert Uzzo, MD, MBA, of Fox Chase Cancer Center discusses an evolution in prostate cancer screening modalities.
The American Urological Association recently released its first guideline update in the medical management of kidney stones ...
Investigators reported initial results from the VAPOR 2 study, which assessed partial gland water vapor ablation in men with grade group 2 prostate cancer.
A phase 2 trial tested the ability of PSMA-radioguided surgery for detecting lymph node metastases in patients with intermediate- or high-risk prostate cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results